You just read:

S*BIO's Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Efficacy in Xenograft Models

News provided by

S*BIO Pte Ltd

Feb 28, 2011, 08:00 ET